BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹648 Cr | ₹653 Cr | ₹504 Cr | ₹544 Cr | ₹562 Cr |
What is the latest Net Current Assets ratio of BLISS GVS PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹648 Cr |
| Mar2024 | ₹653 Cr |
| Mar2023 | ₹504 Cr |
| Mar2022 | ₹544 Cr |
| Mar2021 | ₹562 Cr |
How is Net Current Assets of BLISS GVS PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹648 Cr | -0.90 | |
| Mar2024 | ₹653 Cr | 29.63 | |
| Mar2023 | ₹504 Cr | -7.29 | |
| Mar2022 | ₹544 Cr | -3.17 | |
| Mar2021 | ₹562 Cr | - | |
Compare Net Current Assets of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹2,761.4 Cr | 10.3% | 17.2% | 115.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 10.3% |
17.2% |
115.5% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses